Haemonetics Corp reports results for the quarter ended in September - Earnings Summary

Haemonetics

07/11/2022 12:01

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
83 cents​​ per share for the quarter ended in September. The
mean expectation of eight analysts for the quarter was
for earnings of 67 cents per share.
    * Revenue rose 24% to $297.49 million from a year ago;
analysts
expected $269.22 million. 
    * Haemonetics Corp's reported EPS for the quarter was 64
cents​.
    * The mean earnings estimate of analysts had risen by
about 8.5%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Haemonetics Corp shares had risen by 9.0% this quarter and
gained 52.1% so far this year.
    * The company reported quarterly net income of $33.2
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $88.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 12:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.67           0.83           Beat
 Jun. 30 2022      0.51           0.58           Beat
 Mar. 31 2022      0.60           0.65           Beat
 Dec. 31 2021      0.73           0.84           Beat